Prostate Cancer - Results from #960

REVIEW UroToday

Prostate cancer mortality risk in relation to working underground in the Wismut cohort study of German uranium miners, 1970-2003, "Beyond the Abstract," by Linda Walsh, Florian Dufey, and Michaela Kreuzer December 20, 2012

Consumption of oxygen: A mitochondrial-generated progression signal of advanced cancer, "Beyond the Abstract," by Masahiro Higuchi, PhD December 19, 2012

Management of localized prostate cancer by focal transurethral resection of prostate cancer: An application of radical TUR-PCa to focal therapy, "Beyond the Abstract," by Masaru Morita, MD, PhD and Takeshi Matsuura, MD, PhD December 18, 2012

Quantitative mathematical modeling of PSA dynamics of prostate cancer patients treated with intermittent androgen suppression, "Beyond the Abstract," by Kazuyuki Aihara December 17, 2012

Acid ceramidase-mediated production of sphingosine 1-phosphate promotes prostate cancer invasion through up-regulation of cathepsin B, "Beyond the Abstract," by Thomas Beckham and Xiang Liu December 15, 2012

Sulforaphane, a cruciferous vegetable-derived isothiocyanate, inhibits protein synthesis in human prostate cancer cells, "Beyond the Abstract," by Anna Herman-Antosiewicz, PhD, DSc December 14, 2012

Role of (11)C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphy, "Beyond the Abstract," by Chiara Fuccio, MD December 13, 2012

The efficacy and safety of degarelix, a GnRH antagonist: A 12-month, multicentre, randomized, maintenance dose-finding Phase II study in Japanese patients with prostate cancer, "Beyond the Abstract," by Seiichiro Ozono, MD December 12, 2012

The relationship of the intensity of posttreatment prostate-specific antigen surveillance and prostate cancer outcomes: Results from a population-based cohort, "Beyond the Abstract," by Mohammed Nabhan, MD December 7, 2012

Comparison of biochemical failure definitions for predicting local cancer recurrence following cryoablation of the prostate, "Beyond the Abstract," by Sven Wenske, MD December 5, 2012

Prostate specific antigen levels and prostate cancer detection rates in patients with end stage renal disease, "Beyond the Abstract," by Duane Baldwin, MD December 4, 2012

Genome abnormalities precede prostate cancer and predict clinical relapse, "Beyond the Abstract," by Jianhua Luo, MD, PhD November 29, 2012

Seminal plasma proteins in prostatic carcinoma: Increased nuclear semenogelin I expression is a predictor of biochemical recurrence after radical prostatectomy, "Beyond the Abstract," by Hiroshi Miyamoto, MD, PhD November 28, 2012

Combination effects of docetaxel and doxorubicin in hormone-refractory prostate cancer cells, "Beyond the Abstract," by Younsoo Bae, PhD, et al November 20, 2012

The relationships between preoperative sexual desire and quality of life following radical prostatectomy: A 5-year follow-up study, "Beyond the Abstract," by Shunichi Namiki, MD November 20, 2012

Hyperbaric oxygen therapy for radiation cystitis in patients with prostate cancer: A long-term follow-up study, "Beyond the Abstract," by Teruhiro Nakada, MD November 17, 2012

Docetaxel-induced fatal interstitial pneumonitis in a patient with castration-resistant prostate cancer, "Beyond the Abstract," by Seok Joong Yun, MD, PhD November 13, 2012

Expression changes in the stroma of prostate cancer predict subsequent relapse, "Beyond the Abstract," by Zhenyu Jia November 13, 2012

Washout gradient in dynamic contrast-enhanced MRI is associated with tumor aggressiveness of prostate cancer, "Beyond the Abstract," by Shih-Chieh Jeff Chueh, MD, PhD, et al November 10, 2012

Outcomes of metallic stents for malignant ureteral obstruction, "Beyond the Abstract," by Zach G. Goldsmith, MD, PhD November 8, 2012

Page 49 of 57